UOW Technologies

UOW has a commercialisation model that packages UOW's research technologies into investment-ready spin-out businesses and licence deals.

UOW invests in patent applications, commercialisation advice and business planning to nurture technology development and commercialisation. Once a spin-out is formed, UOW will also enable the company to access UOW's research staff to further develop the research concepts and bring the technology beyond the proof of concept stage.

A range of UOW technologies require private investment to establish their full commercial potential to be realised. In order to take these technologies to the marketplace, investors can participate in the creation or expansion of UOW spin-out companies.

The links below provide an overview of a selection of UOW technologies with investment opportunities. For confidentiality reasons this website does not reveal UOW's complete investment portfolio, but UOW's Managers of Innovation and Commercialisation can facilitate wider access.

• Doped Magnesium Diboride - novel and high performance superconducting material.
• enikos - software for next generation multimedia applications.
• Real Time Dosimetry - quality assurance in real time for prostate brachytherapy.
• Novel Cancer Therapeutic - a cytotoxic compound designed for targeted delivery to cancer cells.
• The Intelligent Kneesleeve- an intelligent fabric joint sleeve for training and rehabilitation of athletes.

Disclaimer: The information on this website has been prepared by the University of Wollongong (UOW) for the purpose of exploring the basic technical and commercial feasibility of a technology and to stimulate discussion. | Please read our full Disclaimer |

Any questions should be directed to the Managers of Innovation and Commercialisation

Last reviewed: 27 November, 2007